ArticleThe Lancet regional health. Europe2026
Effectiveness of a nature-based social prescribing intervention on loneliness and health-related quality of life among vulnerable urban adults (RECETAS-BCN): an observer-blinded randomised controlled trial.
Article in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05488496 (Testing the Effectiveness of a Nature-based Social Intervention on Loneliness Among Lonely Adults in Barcelona - a Randomized Controlled Trial), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Testing the Effectiveness of a Nature-based Social Intervention on Loneliness Among Lonely Adults in Barcelona - a Randomized Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Loneliness is a major public health problem disproportionately affecting vulnerable populations and has well-recognised health consequences. The RECETAS-BCN study tests the effectiveness of 'Friends in Nature (FiN)', a facilitator-led group and nature-based social prescribing (NBSP) intervention, built on existing evidence, to reduce loneliness and improve health-related quality of life (HRQoL) among adults. Methods: In this observer-blinded, parallel randomised controlled trial, we recruited lonely adults (18+), from 12 neighbourhoods with low socioeconomic levels in the Barcelona metropolitan region of Spain. Participants were randomised (1:1) into two NBSP pathways: 1) group-based sessions 1x/week for nine weeks (intervention arm, n = 160), and 2) active signposting (active-control arm, n = 160). Co-primary outcomes were loneliness (De Jong Gierveld Loneliness Scale = DJGLS) and HRQoL (15D). Outcomes were assessed at M0, M3 (primary endpoint), M6, and M12. Trial registration #NCT05488496 at ClinicalTrials.gov. Findings: Between January 10, 2023, and June 11, 2024, 320 (78%) of 411 screened adults (80% female; median age 62.8 years) were randomised. Early dropouts were lower in the intervention arm compared to the active-control arm (14% versus 28%, p = 0.002). One participant in the intervention arm had an adverse event. No significant changes were observed in HRQoL. At M3, both groups showed significant loneliness reductions by 10.5 percent (overall mean change: -0.73; 95% CI -1.04 to -0.42), but no significant between-group difference was observed (0.30; 95% CI -0.26 to 0.86; p = 0.296). Moderation analyses revealed a significant interaction for the baseline composite emotional wellbeing score (CSEW, p = 0.003), indicating that the FiN intervention was significantly more effective than signposting for participants with higher baseline loneliness and lower CSEW. Interpretation: Results suggest that both NBSP pathways alleviated loneliness but did not change HRQoL. These reductions in loneliness continued to increase through one year of follow up. Results point to the promising benefits of NBSP interventions for reducing loneliness in cities. Funding: European Commission H2020 programme.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.